Peritoneal Dialysis International is a peer reviewed, international publication dedicated to peritoneal dialysis. PDI welcomes original contributions dealing with all aspects of peritoneal dialysis from health care professionals and scientists working in the peritoneal dialysis field around the world.
|Jeff Perl||St. Michael's Hospital, Canada|
|Martin Wilkie||Sheffield Teaching Hospitals, Sheffield, UK|
|Yeoungjee Cho||Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia|
|John Crabtree||Harbor-UCLA Medical Center, USA|
|Donald Fraser||School of Medicine, Cardiff University, UK|
|Mark Lambie||University Hospital of North Staffordshire, UK|
|Karine Manera||University of Sydney, Australia|
|Keith MuCullough||Arbor Research Collaborative, USA|
|Rukshana Shroff||Great Ormond Street Hospital for Children NHS Trust, UK|
|Cheuk Chun Szeto||The Chinese University of Hong Kong, Hong Kong|
|Edgar Lerma||University of Illinois at Chicago/ Advocate Christ Medical Center Illinois USA|
|Nicola Matthews||Mackenzie Health, Canada|
|Nikhil Shah||University of Alberta, Canada|
|Georgi Abraham||SRMC, Chennai Nephrology, India|
|Alferso Abrahams||Universitair Medisch Centrum Utrecht, Netherlands|
|Ali Abu Alfa||Yale University School of Medicine, Lebanon|
|Joanne Bargman||University Health Network, Nephrology, Toronto, Canada|
|Neil Boudville||University of Western Australia, Australia|
|Edwina Brown||Hammersmith Hospital, London, UK|
|Gillian Brunier||Sunnybrook Health Sciences Centre, Canada|
|Richard Corbett||Imperial College Healthcare NHS Trust, UK|
|Brett Cullis||Mediclinic Pietermaritzburg, Life Hilton Hospital, St Annes Hospital, South Africa|
|Javier de Arteaga||Hospital privado, Nephrology, Argentina|
|Jie Dong||Peking University First Hospital, China|
|Frank Dor||Imperial College London, UK|
|Soner Duman||Ege University, Izmir, Turkey|
|Stanley Fan||Royal London Hospital Renal Unit, UK|
|Ana Figueiredo||Pontificia Universidade, Brazil|
|Fredric Finkelstein||Hospital of St Raphael Yale University, USA|
|Eric Goffin||UC Louvain, Belgium|
|Olof Heimbürger||Karolinska Institutet, Sweden|
|Arpana Iyengar||St.John's National Academy of Health Sciences, India|
|David Johnson||Princess Alexandra Hospital, Australia|
|Philip K.T. Li||Prince of Wales Hospital, Hong Kong|
|Talerngsak Kanjanabuch||Chulalongkorn University, Thailand|
|Hideki Kawanishi||Tsuchiya General Hospital, Japan|
|Ramesh Khanna||University of Columbia, USA|
|Yong-Lim Kim||Kyungpook National University Hospital, South Korea|
|Norbert Lameire||Universitair Ziekenuis, Belgium|
|John Leypoldt||Baxter Healthcare, USA|
|Adrian Liew||Mount Elizabeth Novena Hospital, Singapore|
|Badri M. Shrestha||Sheffield Kidney Institute, UK|
|Peter Margetts||St. Joseph's Hospital, Canada|
|Rajnish Mehrotra||Kidney Research Institute and Harborview Medical Center, USA|
|David Mendelssohn||Humber River Regional Hospital, Canada|
|M. Miyazaki||Oji Hospital, Japan|
|Johann Morelle||Cliniques universitaires Saint-Luc, Belgium|
|Annie-Claire Nadeau-Fredette||Hôpital Maisonneuve-Rosemont, Canada|
|Iraj Najafi||Tehran University of Medical Sciences, Iran|
|Mihran V. Naljayan||LSUHSC School of Medicine, USA|
|K.Shivanand Nayak||Virinchi Hospital, India|
|Sharon Nessim||Jewish General Hospital, McGill University, Canada|
|Johann Nicholas||The Shrewsbury and Telford Hospital NHS Trust, UK|
|Peter Nourse||Red Cross War Memorial Children's Hospital, South Africa|
|Carl Öberg||Lund University, Sweden|
|Matthew Oliver||Sunnybrook Health Sciences Centre, Canada|
|Alberto Ortiz||Fundacion Jimenez Diaz Dialisis, Spain|
|Miguel Pérez Fontán||Complejo Hospitalario, Spain|
|Beth Piraino||University of Pittsburgh, USA|
|Suma Prakash||Temple University in Philadelphia, USA|
|Thyago Proenca de Moraes||International Liaison of the School of Medicine Pontificia, Brazil|
|Jenny Shen||David Geffen School of Medicine at UCLA, USA|
|Amy Sood||St. Boniface General Hospital, Canada|
|Raymond T. Krediet||Academic Medical Centre, The Netherlands|
|Isaac Teitelbaum||University of Colorado Hospital, USA|
|Emilie Trinh||McGill University Health Center, Canada|
|Laura Troidle||Yale-new Haven Hospital, USA|
|Wim Van Biesen||University Ghent, Belgium|
|Christian Verger||René Dubos Hospital, France|
|Bradley Warady||The Children's Mercy Hospital, USA|
|Janusz Witowski||University Medical School, Poland|
|Graham Woodrow||St. James University Hospital, UK|
|Hui-Kim Yap||Khoo Teck Puat - National University Children's Medical Institute, National University Hospital, Singapore|
Manuscript Submission Guidelines: Peritoneal Dialysis International
This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
This journal follows the Committee on Publication Ethics guidance on dealing with suspected breaches of research or publishing ethics
Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/peritdialint to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.
Only manuscripts of sufficient quality that meet the aims and scope of Peritoneal Dialysis International will be reviewed.
There are no fees payable to submit or publish in this journal.
As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere. Please see our guidelines on prior publication and note that Peritoneal Dialysis International may accept submissions of papers that have been posted on pre-print servers; please alert the Editorial Office when submitting (contact details are at the end of these guidelines) and include the DOI for the preprint in the designated field in the manuscript submission system. Authors should not post an updated version of their paper on the preprint server while it is being peer reviewed for possible publication in the journal. If the article is accepted for publication, the author may re-use their work according to the journal's author archiving policy.
If your paper is accepted, you must include a link on your preprint to the final version of your paper.
- What do we publish?
1.1 Aims & Scope
1.2 Article types
1.3 Writing your paper
- Editorial policies
2.1 Peer review policy
2.6 Declaration of conflicting interests
2.7 Research ethics and patient consent
2.8 Clinical trials
2.9 Reporting guidelines
2.10 Research Data
- Publishing policies
3.1 Publication ethics
3.2 Contributor's publishing agreement
3.3 Open access and author archiving
- Preparing your manuscript
4.2 Artwork, figures and other graphics
4.3 Supplementary material
4.4 Reference style
4.5 English language editing services
- Submitting your manuscript
5.2 Information required for completing your submission
- On acceptance and publication
6.1 SAGE Production
6.2 Online First publication
6.3 Access to your published article
6.4 Promoting your article
- Further information
Before submitting your manuscript to Peritoneal Dialysis International, please ensure you have read the Aims & Scope.
The word, table and figure counts for an article are provided to keep manuscripts at a length that will maintain the interest of our reviewers and readership. Manuscripts that do not adhere to the allotments provided will be returned to the corresponding author for revision before undergoing peer review.
Peer reviewed investigations that represent new and significant contributions to the field. Maximum length 3500 words excluding abstract and references; 40 references; 5 figures and tables; abstract maximum 250 words presented as background, methods, results and conclusion. Content can be supplemented with online only material to be formatted by the author and uploaded with the article using the appropriate template. Where methodology is particularly extensive, more detailed information should be provided in the online only supplemental material. The main text of the paper must stand on its own without the supplemental material.
Reviews of major areas or sub-areas in the field of peritoneal dialysis. These articles may be up to 4000 words in length and have 50 references, 6 tables and figures, brief descriptive abstract.
Views of invited authors on a specific topic where they are recognized experts. 2000 words, 30 references, no abstract.
Controversies and Hypotheses:
Solicited by the editorial team, presented as point-counter point debates; limited to 3000 words total, 30 references, 6 tables and figures, brief abstract.
Clinical Guidelines and Consensus Statements:
These are generally solicited through the International Society of Peritoneal Dialysis (ISPD) guidelines committee and are written by a working group of experts. Concise guideline statements supported by brief evidence will be supplemented by extensive evidence review presented as an online only supplement.
Brief clinical observations or pieces of original research. 1200 words for the main body of text (excluding the abstract) with up to 20 key references, 1 table and 1 figure. An unstructured abstract of 250 words maximum must be included.
Images in PD:
These papers should encompass visual discovery and variations in clinical practice within the diverse peritoneal dialysis (PD) population around the globe. Multimedia (images) must be of high quality, original and not published elsewhere. Examples of suitable images include unusual medical imaging findings (i.e., CT/MRI), PD effluent color changes, physical exam findings (i.e. unusual rash), unusual PD access changes/finding, infrastructure photos (i.e., setup of equipment). Still images should include a version with indicators and labels identifying important structures, and a second image without added indicators and labels. All patient identifying information should be removed; consent to publish should be obtained and declared where this is not possible.
Submissions should include a main document file that briefly describes the clinical context and findings (max 500 words, 15 references), a brief figure legend for the image (max 150 words) and up to 4 images.
Comments on papers published in Peritoneal Dialysis International should be submitted as a letter to the editor. These letters will be limited to 250 words in length, with 4 references.
As solicited by the editorial office.
Journal Cover Images:
Authors are invited to submit scientifically interesting and visually arresting cover images. Illustrations need not be reprinted in the article but should be representative of the work. Appropriate consents, permissions and releases must be obtained where authors wish to include images of patients and any other individuals. Images should be original, and authors grant SAGE, on behalf of the ISPD, the exclusive license to publish. Include a brief caption (50–60 words) and credit information (e.g., Image courtesy of...). Images should be 6 inches wide by 7.25 inches high. Files should be in JPG or TIFF format with a dpi of at least 300. Cover image files may be submitted by email to firstname.lastname@example.org and should be in the following format:
Size: 213mm X 412 mm
Resolution: 600 dpi
Image format: tiffbr
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
Please adapt consensus nomenclature as highlighted in this article.
Please refer to the glossary below for the preferred terminology to be used in submissions:
1.3.1 Make your article discoverable
For information and guidance on how to make your article more discoverable, visit our Gateway page on How to Help Readers Find Your Article Online
SAGE does not permit the use of author-suggested (recommended) reviewers at any stage of the submission process, be that through the web-based submission system or other communication. Reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Our policy is that reviewers should not be assigned to a paper if:
• The reviewer is based at the same institution as any of the co-authors
• The reviewer is based at the funding body of the paper
• The author has recommended the reviewer
• The reviewer has provided a personal (e.g. Gmail/Yahoo/Hotmail) email account and an institutional email account cannot be found after performing a basic Google search (name, department and institution).
**Please note that all manuscripts should be accompanied by a seperate document entitled 'Declarations'.**
Please read the Declarations guidelines for authors, available here carefully before submitting your Declarations document.
This should be submitted under the file designation ‘Declarations’. This must include each of the below headings with the corresponding information. Please note that manuscripts which do not include these Declarations will be returned. These headings will be published at the end of every accepted manuscript, where one of these headings is not applicable please indicate as such under the heading.
1. Conflicting interests
3. Ethical approval
4. Informed consent to participate
5. Informed consent to publish
6. Trial Registration
Example of a completed Declarations document:
Conflicting interests: MS is an employee of XXX. BF has received grants from XXX.
Funding: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: XXX [grant number XXX].
Ethical approval: Ethical approval for this study was obtained from *NAME OF ETHICS COMMITTEE OR INSTITUTIONAL REVIEW BOARD (APPROVAL NUMBER/ID)*.
Informed consent to participate: Written informed consent was obtained from all subjects before the study
Informed consent to publish: Written informed consent was obtained from the patient(s) for their anonymized information to be published in this article.
Trial Registration: *NAME OF TRIAL REGISTRY: TRIAL REGISTRATION NUMBER*
Authorship: BF and NP researched literature and conceived the study. MS was involved in protocol development, gaining ethical approval, patient recruitment and data analysis. BF wrote the first draft of the manuscript. All authors reviewed and edited the manuscript and approved the final version of the manuscript
Acknowledgements: We would like to thank XXX XXXX for his assistance and guidance in this research.
Please read the following information carefully for additional information regarding these declarations.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
- Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
- Drafted the article or revised it critically for important intellectual content,
- Approved the version to be published,
- Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
2.4.1 Third party submissions
Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:
- Disclose this type of editorial assistance – including the individual’s name, company and level of input
- Identify any entities that paid for this assistance
- Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.
Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.
2.4.2 Writing assistance
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.
Peritoneal Dialysis International requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Peritoneal Dialysis International to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here
Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.
Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The Journal has adopted the ARRIVE guidelines.
Peritoneal Dialysis International endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives
The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.
Subject to appropriate ethical and legal considerations, authors are encouraged to:
- share your research data in a relevant public data repository
- include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
- cite this data in your research
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway
Peritoneal Dialysis International and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
3.1.2 Prior publication
If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway
Peritoneal Dialysis International offers optional open access publishing via the SAGE Choice programme. For more information on Open Access publishing options at SAGE please visit SAGE Open Access. For information on funding body compliance, and depositing your article in repositories, please visit SAGE’s Author Archiving and Re-Use Guidelines and Publishing Policies.
The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.
For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines
Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplemental files.
Peritoneal Dialysis International adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
Peritoneal Dialysis International is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/peritdialint to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a unique and persistent digital identifier that distinguishes researchers from every other researcher, even those who share the same name, and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities, ensuring that their work is recognized.
The collection of ORCID IDs from corresponding authors is now part of the submission process of this journal. If you already have an ORCID ID you will be asked to associate that to your submission during the online submission process. We also strongly encourage all co-authors to link their ORCID ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID ID will become part of your accepted publication’s metadata, making your work attributable to you and only you. Your ORCID ID is published with your article so that fellow researchers reading your work can link to your ORCID profile and from there link to your other publications.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. The affiliation listed in the manuscript should be the institution where the research was conducted. If an author has moved to a new institution since completing the research, the new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway
Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be made available to the corresponding author via our editing portal SAGE Edit or by email, and corrections should be made directly or notified to us promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.
Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.
SAGE provides authors with online access to their final article.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.
Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Peritoneal Dialysis International editorial office as follows: Vineeta.Gawai@sagepub.in
7.1 Appealing the publication decision
Editors have very broad discretion in determining whether an article is an appropriate fit for their journal. Many manuscripts are declined with a very general statement of the rejection decision. These decisions are not eligible for formal appeal unless the author believes the decision to reject the manuscript was based on an error in the review of the article, in which case the author may appeal the decision by providing the Editor with a detailed written description of the error they believe occurred.
If an author believes the decision regarding their manuscript was affected by a publication ethics breach, the author may contact the publisher with a detailed written description of their concern, and information supporting the concern, at email@example.com